Europe In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagent and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Country 2024-2032

Europe In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagent and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A11054
Buy Now

Market Overview:

The Europe in vitro diagnostics market size is projected to exhibit a growth rate (CAGR) of 5.1% during 2024-2032. The increasing focus improving healthcare infrastructure, utilization of advanced technologies, escalating investment in healthcare by the public and private sectors, growing incidences of chronic illnesses, rising geriatric population, and shift towards personalized medicine represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate 2024-2032 5.1%


In vitro diagnostics (IVD) refers to a diverse array of medical tests and procedures conducted on human-derived samples, such as blood or tissue, to diagnose diseases, detect infections, monitor therapeutic drug applications, and pinpoint specific medical conditions. It includes immunochemistry, hematology, clinical chemistry, genetic testing, microbiology, and molecular diagnostics. IVD comprises various components, such as reagents, instruments, and specialized software, that are used across different healthcare environments. It is widely used in areas, such as healthcare, research laboratories, academic entities, pharmaceuticals, public health bodies, biotechnology firms, forensic science, veterinary applications, environmental assessments, and food and beverage (F&B) safety protocols. IVD aids in precise diagnosis, swift detection of diseases, stratification of patients for tailored treatment, planning of individualized treatment, elimination of unnecessary interventions, economic efficiency, and the amplification of overall healthcare effectiveness. In addition, it provides multiple advantages, such as heightened efficiency, pinpoint accuracy, steadfast reliability, promptness, scalability, flexibility, personalization, adherence to safety norms, conformity with regulatory mandates, active contribution to preventive healthcare measures, and the promotion of patient well-being and comfort.

Europe In Vitro Diagnostics Market Trends:

The increasing focus on improving healthcare infrastructure by the European governments and regulatory bodies is propelling the market growth. Furthermore, the utilization of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) in diagnostics to improve accuracy, reduce errors, and provide timely results is contributing to the market growth. Additionally, the escalating investment in healthcare by the public and private sectors to enhance diagnostic capabilities is strengthening the market growth. Apart from this, the growing incidences of chronic illnesses, such as diabetes and cardiovascular diseases (CVDs), which necessitate early and accurate diagnosis, are fueling the market growth. In addition, the rising geriatric population, which requires more extensive healthcare, including regular monitoring and testing, is catalyzing the market growth. Besides this, the shift towards personalized or precision medicine in Europe is facilitating the demand for more advanced diagnostic tools, such as IVD. Moreover, the heightened awareness among healthcare providers and patients about the importance of early diagnosis to prevent complications, reduce treatment costs, and enable timely intervention is positively impacting the market growth. Along with this, the rapid proliferation of private laboratories offering specialized testing services across Europe, thus enhancing accessibility to IVD, is favoring the market growth. In addition, the introduction of stringent regulations to ensure the safety, efficacy, and environmental sustainability of IVD products is bolstering the market growth.

Europe In Vitro Diagnostics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Europe in vitro diagnostics market report, along with forecasts at the regional and country levels for 2024-2032. Our report has categorized the market based on test type, product, usability, application, and end user.

Test Type Insights:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the test type. This includes clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and others.

Product Insights:

  • Reagent and Kits
  • Instruments
     

The report has provided a detailed breakup and analysis of the market based on the product. This includes reagent and kits and instruments.

Usability Insights:

  • Disposable IVD Devices
  • Reusable IVD Devices
     

The report has provided a detailed breakup and analysis of the market based on usability. This includes disposable and reusable IVD devices.

Application Insights:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others
     

The report has provided a detailed breakup and analysis of the market based on application. This includes infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others.

End User Insights:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-of-care Testing Centers
  • Academic Institutes
  • Patients
  • Others
     

The report has provided a detailed breakup and analysis of the market based on end user. This includes hospitals laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.

Country Insights:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Germany, France, United Kingdom, Italy, Spain, and others.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Europe In Vitro Diagnostics Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Test Type
  • Product
  • Usability
  • Application
  • End User
  • Country 
Test Types Covered Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, Others
Products Covered Reagent and Kits, Instruments
Usabilities Covered Disposable IVD Devices, Reusable IVD Devices
Applications Covered Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, Others
End Users Covered Hospitals Laboratories, Clinical Laboratories, Point-of-care testing centers, Academic Institutes, Patients, Others
Countries Covered Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Europe in vitro diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Europe in vitro diagnostics market?
  • What is the breakup of the Europe in vitro diagnostics market on the basis of test type?
  • What is the breakup of the Europe in vitro diagnostics market on the basis of product?
  • What is the breakup of the Europe in vitro diagnostics market on the basis of usability?
  • What is the breakup of the Europe in vitro diagnostics market on the basis of application?
  • What is the breakup of the Europe in vitro diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Europe in vitro diagnostics market?
  • What are the key driving factors and challenges in the Europe in vitro diagnostics market?
  • What is the structure of the Europe in vitro diagnostics market and who are the key players?
  • What is the degree of competition in the Europe in vitro diagnostics market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Europe in vitro diagnostics market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the Europe in vitro diagnostics market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Europe in vitro diagnostics industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Europe In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagent and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More